News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

ANTHEM-UC unlocks psoriasis drug potential in ulcerative colitis
26 May 2026
byAudrey Abella
Icotrokinra—the first and only targeted oral peptide designed to selectively block the interleukin-23 receptor (IL-23R), which has been approved for the treatment of plaque psoriasis—shows multiple favourable signals for the treatment of ulcerative colitis (UC), according to updated data from the phase IIb ANTHEM-UC study.
ANTHEM-UC unlocks psoriasis drug potential in ulcerative colitis
26 May 2026
Valid tests needed to detect smell, taste impairments in children with long COVID
26 May 2026
byStephen Padilla
Hyposmia and hypogeusia are not unique to children with acute SARS-CoV-2 infection in the omicron era, but long COVID can cause continuing taste and smell impairments that are not detected by validated questionnaires, according to a study.







